Oncimmune Holdings plc (LON:ONC – Get Rating) shares reached a new 52-week low on Friday . The company traded as low as GBX 42 ($0.49) and last traded at GBX 42 ($0.49), with a volume of 18553 shares. The stock had previously closed at GBX 44.50 ($0.52).
Oncimmune Price Performance
The company has a market cap of £29.18 million and a price-to-earnings ratio of -4.12. The business has a 50-day moving average price of GBX 59.30 and a 200 day moving average price of GBX 80.48. The company has a current ratio of 0.66, a quick ratio of 0.63 and a debt-to-equity ratio of 677.62.
Insider Activity
In other news, insider Adam Hill bought 8,005 shares of the business’s stock in a transaction dated Wednesday, September 21st. The stock was bought at an average price of GBX 62 ($0.73) per share, for a total transaction of £4,963.10 ($5,832.08).
Oncimmune Company Profile
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Articles
Receive News & Ratings for Oncimmune Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oncimmune and related companies with MarketBeat.com’s FREE daily email newsletter.